608,00 € excl.VAT
TCL1 (T cell leukaemia/lymphoma 1) protein is a 14 kDa proto-oncogene that regulates intracellular signalling in T cells. Its gene, located at 14q32.1, is overexpressed in T prolymphocytic leukaemia (T-PLL) due to chromosomal rearrangements that place it next to regulatory elements of the T-cell receptor. TCL1 activates the Akt pathway, promoting phosphorylation of key substrates in cell differentiation, growth and survival. Although involved in T tumours, it is also expressed in normal immune cells, such as thymic precursors and immature B cells. Its overexpression is linked to premalignant clonal expansion and mature T leukaemias.
| Clone | |
|---|---|
| Conjugated | |
| Tested Applications | |
| Size | |
| Regulatory Status | |
| Isotype | |
| Format | |
| Species Reactivity | |
| Protocol | |
| Volumen/test | |
| Almacenamiento | Store in the dark at 2-8 ºC |
| Otros nombres | T-cell leukemia/lymphoma protein 1A (TCL1A), protein p14 TCL1, oncogene TCL-1 |
| Buffer | Aqueous buffered solution containing protein stabilizer and 0.09% sodium azide (NaN 3 ). |
| Immunogen | The TCL1 monoclonal antibody derives from outer α-loop region of TCL1 peptide. |
| Concentración | 0,05 mg/ml |
Immunostep’s anti-human T cell leukemia/lymphoma 1 (TCL1) antibody, clone 1-21, is a monoclonal antibody designed for the identification and enumeration of TCL1 protein, a 14 kDa proto-oncogene product involved in the intracellular regulation of T cell signaling.
This antibody is intended for use in flow cytometry to detect TCL1 expression in various cell types, including immature cortical thymocytes, activated peripheral T cells, pro-B cells, and naive mantle zone B cells of peripheral lymphoid tissues.
Technical Data Sheet (TDS) – (English). Safety Sheet (MSDS) – (English)
| Product description | Reference | Title | Authors | Journal | Year | |
|---|---|---|---|---|---|---|
| Product description | Reference | Title | Authors | Journal | Year |